Inflammation i bukspottkrteln (pankreatit) svr ihllande magsmrta som strlar mot ryggen
Our pipeline and drug surveillance teams continuously monitor new drug launches, formulations, and indications of GLP-1s
Common side effects of both Mounjaro and Wegovy include: Nausea and gastrointestinal issues Decreased appetite , useful for weight loss Risk of pancreatitis , a serious concern Mounjaro tends to have a higher incidence of gastrointestinal side effects, affecting around 12% to 18% of users
Weight loss may be slower, but if the lower dose is sustainable and still producing results, that is a reasonable approach
Results still occur but may be in the lower range of expected outcomes
The hope for the branded companies is theyll launch these newer, better agents and be able to capture a growing slice of that now really big pie. About the authors Cassie McGrath Cassie McGrath is a reporter at Healthcare Brew, where she focuses on the inner-workings and business of hospitals, unions, policy, and how AI is impacting the industry